Earnings Preview For CytomX Therapeutics
Portfolio Pulse from Benzinga Insights
CytomX Therapeutics (NASDAQ:CTMX) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.20. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. The company's shares were trading at $1.69 as of August 04, with a 52-week increase of 6.56%.
August 07, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CytomX Therapeutics is expected to announce its Q2 earnings. The company has a history of beating EPS estimates, which could potentially lead to a share price increase.
CytomX Therapeutics has a history of beating EPS estimates, which has often led to an increase in its share price. If the company beats the EPS estimate again, it could potentially lead to a short-term increase in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100